title: Shared scheme for assessing drugs for multiple sclerosis: dealing with uncertainties about cost effectiveness of treatments is difficult problem.
authors.forename: David
authors.initials: D
authors.lastname: Chadwick
authors.forename: Richard
authors.initials: R
authors.lastname: Gray
mesh_terms: D001379:Azathioprine / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000191:economics* / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy*; D020414:Risk Sharing, Financial
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine